ArticleGenes2026
Hypoglycemic Agent Targets and Susceptibility to Lower Respiratory Infection: A Pharmacogenomic Mendelian Randomization Study.
Taikang Yao, Nan Wu, Yanqiu Ma, Zilu Wang, Beibei Liu, Ming Lu, Zhenchao Wu, Ning Shen
Abstract read
In one paragraphArticle in Genes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Taikang YaoDepartment of Pulmonary and Critical Care Medicine, Peking University Third Hospital, No. 49 Huayuan North Road, Haidian District, Beijing 100191, China.ORCID 0000-0002-0497-0595 Nan WuDepartment of Respiratory and Critical Care Medicine, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing 100044, China.
Yanqiu MaDepartment of Pulmonary and Critical Care Medicine, Peking University Third Hospital, No. 49 Huayuan North Road, Haidian District, Beijing 100191, China.
Zilu WangDepartment of Pulmonary and Critical Care Medicine, Peking University Third Hospital, No. 49 Huayuan North Road, Haidian District, Beijing 100191, China.
Beibei LiuDepartment of Pulmonary and Critical Care Medicine, Peking University Third Hospital, No. 49 Huayuan North Road, Haidian District, Beijing 100191, China.
Ming LuDepartment of Pulmonary and Critical Care Medicine, Peking University Third Hospital, No. 49 Huayuan North Road, Haidian District, Beijing 100191, China.
Zhenchao WuDepartment of Pulmonary and Critical Care Medicine, Peking University Third Hospital, No. 49 Huayuan North Road, Haidian District, Beijing 100191, China.ORCID 0000-0002-1342-8773 Ning ShenDepartment of Pulmonary and Critical Care Medicine, Peking University Third Hospital, No. 49 Huayuan North Road, Haidian District, Beijing 100191, China.ORCID 0000-0003-2352-0677 Funding
Beijing Key Clinical Specialty Funding 010071National Natural Science Foundation of China 7242165the Research Project of Peking University Third Hospital in National Key Laboratory of Vascular Homeostasis and Remodeling 2024-VHR-SY-04
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Diabetes Mellitus, Type 2Hypoglycemic AgentsRespiratory Tract InfectionsGenetic Predisposition to DiseaseHumansInsulinMendelian Randomization AnalysisMetforminPharmacogeneticsPolymorphism, Single NucleotidePPAR gammaPPAR-gamma AgonistsHypoglycemic AgentsInsulinMetforminPPAR gammaPPAR-gamma Agonistsdrug-target mendelian randomizationgenetic instrumentslower respiratory tract infectionpneumoniaPPARGsepsistype 2 diabetes
Identifiers
PMID42938374
PMCPMC13704145
What OpenQuestion holds
Textmetadata
Read underepoch 390